This article provides a collection of new infectious diseases & antimicrobial stewardship literature published in May of 2019. Hot off the press, many of these have been released e-pub only. We put these noteworthy publications together here in one place for your convenience!
Written By: Bassam Ghanem, Pharm.D., MS, BCPS
Edited By: Timothy P. Gauthier, Pharm.D., BCPS-AQ ID
[Last updated: 2 June 2019]
In this monthly column two pharmacists who utilize Twitter to stay current with antimicrobial stewardship literature (@ABsteward [B.G.] & @IDstewardship [T.G.]) identify some of the top hot off the press articles recently published.
The following are some of the new publications we found most interesting or noteworthy that were released in May of 2019…
1. Gentamicin compared with ceftriaxone for the treatment of gonorrhoea (G-ToG): a randomised non-inferiority trial | Lancet
https://www.sciencedirect.com/science/article/pii/S0140673618328174
G-ToG RCT found that gentamicin did not reach the non-inferiority margin compared to ceftriaxone for the treatment of gonorrhoea, with both groups also given a single dose of azithromycin by mouth.
2. Risk for Tympanic Membrane Perforation after Quinolone Ear Drops for Acute Otitis Externa | CID
This large cohort study found that the use of quinolone ear drops was associated with increased risk for tympanic membrane perforation compared with neomycin plus hydrocortisone.
3. Prophylactic antibiotics in the prevention of infection after operative vaginal delivery (ANODE): a multicentre randomised controlled trial | Lancet
ANODE trial showed that a single prophylactic dose of intravenous amoxicillin and clavulanic acid a median of 3 h after operative vaginal delivery halved maternal infection rate and reduce overall antibiotic use.
4. No Clinical Benefit to Treating Male Urinary Tract Infection Longer than Seven Days: An Outpatient Database Study | OFID
https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofz216/5486159
This multi-clinic study concluded that men with UTI without evidence of complicating conditions do not need to be treated for longer than 7 days.
5. Antibiotic treatment versus no treatment for asymptomatic bacteriuria in kidney transplant recipients: a multicenter randomized trial | OFID
https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofz243/5494787
This RCT found that antibiotic treatment of ASB did not prevent acute graft pyelonephritis in kidney transplant recipients and may increase antibiotic resistance.
6. Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial | JAC
This RCT found no statistically significant difference in the rates of clinical or microbiological remission between patients randomized to only 4 compared with 6 weeks of systemic antibiotic therapy following removal of an infected osteoarticular implant.
7. Beta-Lactam/Beta-Lactamase Inhibitor Therapy for Potential AmpC-Producing Organisms: A Systematic Review and Meta-Analysis | OFID
https://academic.oup.com/ofid/advance-article/doi/10.1093/ofid/ofz248/5498096?searchresult=1
This systematic review and meta-analysis found no significant difference in 30-day mortality between beta-lactam/beta-lactamase inhibitors and carbapenems in the treatment of bloodstream infections with AmpC-Producing pathogens.
8. Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015 | JAMA
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2734798
This large cohort study found that more than 80% of antibiotic prophylaxis prescriptions before dental procedures are unnecessary.
Additional New & Notable Publications
CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions | ERS
A Reappraisal of Linezolid Dosing in Renal Impairment to Improve Safety | AAC
Total duration of antimicrobial therapy resulting from inpatient hospitalization | ICHE
Periprosthetic joint infections as a consequence of bacteremia | OFID
Dose, Timing, and Type of Infant Antibiotic Use and the Risk of Childhood Asthma | CID
Evaluation of early clinical failure criteria for Gram-negative bloodstream infections | CMI
Two cases of severe neutropenia in patients on low-dose methotrexate and ceftriaxone | AJHP
Antibiotic stewardship in the intensive care unit: Challenges and opportunities | ICHE
Understanding and Addressing CLSI Breakpoint Revisions: a Primer for Clinical Laboratories | JCM
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B | CID
The new, new daptomycin breakpoint for Enterococcus spp. | JCM
Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside | AAC
Eravacycline: The Tetracyclines Strike Back | Annals of pharmacotherapy
How scientists and physicians use Twitter during a medical congress | CMI
RECOMMENDED TO YOU